Insulin glargine (Toujeo) is now FDA approved for children ages 6 and older with type 1 and 2 diabetes. Previously, Toujeo was indicated for people ages 18 and older with type 1 and 2 diabetes. To learn more about the results EDITION JUNIOR trial, please click below.
https://www.biospace.com/article/fda-approves-sanofi-s-toujeo-for-pediatric-diabetes/
Please share your thoughts and subscribe to receive my blogs.
#pediatrics #diabetes #Toujeo
Follow me on Twitter and Facebook @ReecesPiecesDi and Instagram.